• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

142.09 -0.06 (-0.04%)
Streaming Delayed Price Updated: 12:35 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
July 17, 2023
From Glaukos Corporation
Via Business Wire
News headline image
These 2 Soaring Stocks Finished the Week Strong ↗
July 14, 2023
Wall Street coasted into the close on Friday but still had a good week. 
Via The Motley Fool
News headline image
Where Glaukos Stands With Analysts ↗
July 14, 2023
 
Via Benzinga
News headline image
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday ↗
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
July 12, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know ↗
June 26, 2023
 
Via Benzinga
News headline image
8 Analysts Have This to Say About Glaukos ↗
June 26, 2023
 
Via Benzinga
News headline image
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade ↗
June 07, 2023
Piper Sandler has upgraded Glaukos Corporation (NYSE: GKOS) to Overweight from a Neutral ra 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 ↗
June 07, 2023
 
Via Benzinga
News headline image
Analyst Expectations for Glaukos's Future ↗
June 05, 2023
 
Via Benzinga
News headline image
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
June 05, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in the William Blair Growth Stock Conference
May 24, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos: Q1 Earnings Insights ↗
May 03, 2023
 
Via Benzinga
News headline image
Expert Ratings for Glaukos ↗
April 18, 2023
 
Via Benzinga
News headline image
Earnings Preview For Glaukos ↗
February 21, 2023
 
Via Benzinga
News headline image
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday ↗
May 08, 2023
With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
May 05, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces First Quarter 2023 Financial Results
May 03, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting
May 01, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces the Release of its 2022 Sustainability Report
April 19, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3
April 12, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It ↗
March 09, 2023
Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.  
Via Benzinga
News headline image
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
From Glaukos Corporation
Via Business Wire
News headline image
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday ↗
February 23, 2023
Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose... 
Via Benzinga
News headline image
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in the Citi Healthcare Conference
February 15, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
February 01, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability
January 10, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programs
January 10, 2023
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 28, 2022
From Glaukos Corporation
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap